# MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)

Study · id `cardio:ct-nct05487612` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05487612](<https://clinicaltrials.gov/study/NCT05487612>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05487612

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1300 participants.

## Technical summary

Registry record NCT05487612. Randomized; single masking; primary purpose treatment. Start 2022-05-26 (actual); primary completion 2028-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1300 participants (planned count; ClinicalTrials.gov record NCT05487612, source copy `cardio:ctgov-nct05487612-2026-03-30`, retrieved 2026-10-26)
- Started: 2022-05-26 (actual) (ClinicalTrials.gov record NCT05487612, source copy `cardio:ctgov-nct05487612-2026-03-30`, retrieved 2026-10-26)
- Primary completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT05487612, source copy `cardio:ctgov-nct05487612-2026-03-30`, retrieved 2026-10-26)
- Completion: 2029-03-31 (anticipated) (ClinicalTrials.gov record NCT05487612, source copy `cardio:ctgov-nct05487612-2026-03-30`, retrieved 2026-10-26)
- Countries: Canada; Germany; Greece; Italy; Türkiye; United Kingdom (ClinicalTrials.gov record NCT05487612, source copy `cardio:ctgov-nct05487612-2026-03-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05487612-2026-03-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)
- Acronym: MiECS
- Condition: Coronary Artery Disease
- Condition: Aortic Valve Stenosis
- Condition: Extracorporeal Circulation; Complications
- Intervention (Device): Minimal Invasive Extracorporeal Circulation
- Intervention (Device): Conventional cardiopulmonary bypass
- Lead sponsor: Aristotle University Of Thessaloniki
- Lead sponsor class: OTHER
- Collaborator: Minimal Invasive Extracorporeal Technologies International Society (MiECTiS)
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Aristotle University Of Thessaloniki (`cardio:org-aristotle-university-of-thessaloniki`)

## Provenance

Content hash: 27d4a7ffb4700d83e398915b41b6cd3d781701edf5cd1c0413fc76656957f175
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
